Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Bile-Binding Foods to Reduce Upper Gastrointestinal Bile Acid Concentrations
NCT07303738Phase 4Recruiting
- Sponsor
- Boston Children's Hospital
- Start
- Dec 2025
- Primary completion
- Aug 2030
- Countries
- 1
01
Overview
Phase 4, randomised trial in Avoidant/Restrictive Food Intake Disorder (ARFID) and pulmonary aspiration (3 arms), sponsored by Boston Children's Hospital. Primary endpoint: Gastric bile acid concentration at 4 hours. Started Dec 2025; status: recruiting.
02
Conditions
Avoidant/Restrictive Food Intake Disorder (ARFID)pulmonary aspiration
Beyond the preview
Go deeper on NCT07303738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07303738.